Hartford HealthCare Cancer Institute at the Hospital of Central Ct is a clinical research site located in Hartford, Connecticut, United States 06053.
Crixeo Clinical Trials Trust Score: 92/100 (GOOD). This profile has not yet been claimed by the site owner.
Hartford HealthCare Cancer Institute at the Hospital of Central Ct has participated in 1 clinical trials.
Therapeutic areas: Recurrent Platinum Resistant Ovarian Cancer.
Sponsors: Vascular Biogenics Ltd. operating as VBL Therapeutics.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Connecticut · View every site in Hartford
Trust Score: 92/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Hartford HealthCare Cancer Institute at the Hospital of Central Ct has a Crixeo Trust Score of 92/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Hartford HealthCare Cancer Institute at the Hospital of Central Ct has 1 clinical trials on record. Their work covers Recurrent Platinum Resistant Ovarian Cancer.
Hartford HealthCare Cancer Institute at the Hospital of Central Ct has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.